While this defect was suggested by others to recapitulate key hallmarks of ALT-positive cancers, our study also links the increased propensity for TIFs in Atrx-deleted sarcomas to increased mitotic catastrophe and necrosis after treatment with radiation therapy. This evidence concerns the gene ATRX and cancer.